NCT05584332 2023-07-21A Phase â…¢ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy FemalesShanghai Bovax Biotechnology Co., Ltd.Phase 3 Terminated3,131 enrolled